Clinical Trial Update: Safety Surveillance of Pneumococcal 13-valent Conjugate Vaccine Among Filipinos

View source ↗

Summary

This study conducted safety surveillance of the Pneumococcal 13-valent Conjugate Vaccine (PCV13) in Filipinos, with results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Disease

Drugs mentioned

• Prevnar 13 (pneumococcal conjugate vaccine)

Snippet

Sponsor: Pfizer | Conditions: Pneumococcal Disease | Status: COMPLETED | Results posted: 2017-01-30